Launched last year, the Cancer Patients’ Voice online platform lets patients and the public shape research and care at – and it’s already benefiting patients.

A new digital platform is transforming how researchers access and analyse cancer patient data.

A new referral pathway developed by Royal Marsden researchers aims to speed up diagnosis and reduce anxiety for patients with suspected head and neck cancer. 

Artificial intelligence could help us to assess scans of patients with bone disease, thanks to an innovative software toolkit developed at the BRC.

Experts at The Royal Marsden and The Institute of Cancer Research, with support from the NIHR BRC at The Royal Marsden and ICR, are leading on pioneering cancer research, with their work being published in high-profile journals.

Researchers at The Royal Marsden NHS Foundation Trust, the Francis Crick Institute and University College London have found immune cell patterns in tumours that can help predict whether patients with kidney cancer will respond to immunotherapy. 

A local breast cancer prevention project is aiming to inform and empower women to make lifestyle changes to reduce their risk of developing the disease. 

Artificial Intelligence has helped researchers make major progress in treating an incurable childhood brain cancer. 

Pioneered at The Royal Marsden NHS Foundation Trust, with support from the NIHR BRC at The Royal Marsden and ICR, liquid biopsies allow clinicians at The Royal Marsden to personalise treatments for a range of cancers and spot recurring disease sooner using a simple blood test. 

Dr Hardeep Singh Kalsi is a Clinical Research Fellow, whose role is funded by The Royal Marsden Cancer Charity, and member of the NIHR BRC’s Early Diagnosis & Detection team.